ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast of Editas Medicine Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Editas Medicine EDIT at this time. Stock is rising and might rise more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!

My analysis of Editas Medicine is bullish for shortterm, and stock might move up till 3.6 or till 4.1. Use a stoploss of 3.16 and if this stock hits its stoploss, then it can fall down till 2.71

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

US Stock Market: Private credit lending slumps in Q2 despite rebound in fundraising US private credit funds raised significant capital in the second quarter. Direct lending activity, however, saw a sharp decline during the same period. This divergence highlights investor capital outpacing available new lending opportunities. Private equit - NEWS as on 2026-07-10 indiatimes.com

Bank credit growth to ease as corporates tap bond markets, overseas funding: CareEdge Bank credit growth is expected to moderate gradually in the upcoming fiscal year. Large corporations will increasingly use domestic bond markets and overseas borrowings for funding. The Reserve Bank of India's policy measures make external funding more att - NEWS as on 2026-07-09 indiatimes.com

Credit cards are losing ground to small personal loans, TransUnion CIBIL data shows Credit cards are losing share in India's unsecured lending market as consumers increasingly opt for small-ticket personal loans and other consumption-linked credit, according to a TransUnion CIBIL report. - NEWS as on 2026-07-08 indiatimes.com

Manufacturing MSME credit growth slows to three-year low: Report Manufacturing MSMEs are experiencing the slowest credit growth in three years, raising concerns about lenders' strategies. Only 41% of registered small businesses have accessed formal credit, and the share of new borrowers is declining. While trades and se - NEWS as on 2026-07-03 indiatimes.com

India's private credit market doubles to billion AUM in five years: Report India's private credit market is booming, nearly doubling to billion in assets under management over five years, fueled by strong business demand. The Insolvency and Bankruptcy Code has boosted lender confidence, enabling financing for stressed firms. - NEWS as on 2026-07-02 indiatimes.com

SBI Cards tops credit card additions in May as industry hits 12 crore milestone; spends grow 6.3% YoY India's credit card sector has surpassed 12 crore cards, with new additions surging 33.7% year-on-year in May 2026. Despite robust cardholder growth, spending saw a modest 6.3% increase. SBI Cards led in new card issuance, while ICICI Bank and HDFC Bank al - NEWS as on 2026-06-25 indiatimes.com

Banks boost renewable energy credit by 7% in April amid energy security concerns Banks are boosting credit to renewable energy projects, with a 7% jump in April, as global conflicts highlight India's reliance on oil. This surge in funding for green energy underscores the nation's commitment to energy transition. Experts note a growing - NEWS as on 2026-06-24 indiatimes.com

RBI says UPI-linked credit lines must follow same rules as traditional loans; Closes regulatory arbitrage The Reserve Bank of India has mandated uniform prudential treatment for all credit facilities, including those disbursed via UPI. This move closes a regulatory loophole allowing banks to offer lighter treatment to UPI-linked credit. Now, the nature of the - NEWS as on 2026-06-23 indiatimes.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 3.52
  • 12Day Average: 3.28
  • 20Day Average: 3
  • 50Day Average: 2.95
  • 100Day Average: 2.75
  • 150Day Average: 2.55
  • 200Day Average: 2.69

EDIT Indicators & signals

Indicator MACD (12,26,9)

3.29, 3.1, 0.14
Indicator MACD is in positive zone

Indicator ADX (14)

22.22, 22.58, 35.48
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
10 Fri Jul 2026 3.26 2.96 to 3.30 -0.91% 1.01 times
09 Thu Jul 2026 3.29 3.26 to 3.72 -10.11% 0.99 times
08 Wed Jul 2026 3.66 3.54 to 3.82 -2.4% 0.67 times
07 Tue Jul 2026 3.75 3.52 to 3.82 2.74% 0.81 times
06 Mon Jul 2026 3.65 3.55 to 3.79 0% 0.97 times
02 Thu Jul 2026 3.65 3.17 to 3.68 10.94% 1.23 times
01 Wed Jul 2026 3.29 3.13 to 3.49 1.23% 0.85 times
30 Tue Jun 2026 3.25 3.11 to 3.32 1.56% 0.47 times
29 Mon Jun 2026 3.20 2.87 to 3.23 12.28% 1 times
26 Fri Jun 2026 2.85 2.72 to 2.93 4.01% 2.1 times
25 Thu Jun 2026 2.74 2.65 to 2.97 -2.14% 0.91 times
24 Wed Jun 2026 2.80 2.76 to 2.97 1.45% 1.25 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top